Sign inJoin waitlistJoin the waitlist

DG

Daniel Gruener

Psychiatry & Neurology / Pain Medicine

Credentials: ·

Research

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C
Journal of Hepatology · 2012 · 130 citations
Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C
Antiviral Therapy · 2015 · 29 citations
A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4
Journal of Hepatology · 2014 · 19 citations

Eric Lawitz
3 papers
LW
Lynn Webster
3 papers
JM
John McHutchison
2 papers
RM
Ricky Mofsen
2 papers
TM
Thomas Marbury
2 papers
AM
Abel Murillo
1 paper
AA
Albert Allen
1 paper
AG
Anuj Gaggar
1 paper
BF
Bradley Freilich
1 paper
BV
Bradley Vince
1 paper
DH
David Hassman
1 paper
DK
David Krefetz
1 paper